4/A//SEC Filing
Girshick Birgit 4/A
Accession 0001127602-24-002811
CIK 0001100682other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:34 PM ET
Size
8.3 KB
Accession
0001127602-24-002811
Insider Transaction Report
Form 4/AAmended
Girshick Birgit
Corporate Executive VP & COO
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2024-01-10−5,916→ 0 totalExercise: $144.67From: 2020-02-22Exp: 2024-02-22→ Common Stock (5,916 underlying) - Exercise/Conversion
Common Stock
2024-01-10$144.67/sh+5,916$855,868→ 50,365 total - Tax Payment
Common Stock
2024-01-10$213.14/sh−4,617$984,067→ 45,748 total
Footnotes (1)
- [F1]The transaction was executed as a net exercise, in which no shares were purchased or sold in the open market.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001732091
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:34 PM ET
- Size
- 8.3 KB